Latest Updates of Key Players in the AI-based Surgical Robots Market
Company Profile
| Company | Headquarters | Latest Update |
| Accuray Incorporated | United States | In October 2025, Accuray Incorporated announced that 5D Clinics had treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7 System. |
| Intuitive Surgical, Inc | United States | Intuitive Surgical's Ion system received Food and Drug Administration clearance for software that integrates AI for navigation in lung biopsy events and enhances imaging abilities. |
| Medtronic, plc | Ireland | Medtronic doubles London presence to create worldwide hub for AI and robotics in surgery. |
| Medrobotics Corporation | United States | Medrobotics has been recognized for advances in technology, predominantly in flexible endoscopes. |
| Zimmer Biomet | United States | Zimmer Biomet is changing surgical robotics by integrating AI and data-driven services to enhance precision and patient results. |
| Stereotaxis, Inc. | United States | Stereotaxis is an innovator and worldwide leader in novel surgical robotics for negligibly invasive endovascular intervention. |
Market Growth
The global AI-based surgical robots market size was estimated at USD 10.85 billion in 2025 and is predicted to increase from USD 12.91 billion in 2026 to approximately USD 61.49 billion by 2035, expanding at a CAGR of 18.94% from 2026 to 2035.
Recent Developments in the AI-based Surgical Robots Market
- In December 2025, a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, Shoulder Innovations, Inc., announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery.
- In November 2025, a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, IMPLANET, announced the signing of a partnership agreement with 8i Robotics Inc.
- In July 2025, Care Hospitals, Hyderabad, unveiled the AI-powered Stryker Mako Robotic System, which will assist in robotic-assisted joint replacement surgeries.
- In July 2025, Zimmer Biomet Holdings, Inc., and Monogram Technologies Inc. announced they had entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of stock of Monogram for an upfront payment of $4.04 per share in cash, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.
Stop juggling reports. Manage your entire AI-based Surgical Robots Market data in one seamless space - Access the Dashboard
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
